• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉扩张患者循环中蛋白水解、炎症和神经激素标志物之间的时间关联。

Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia.

作者信息

Finkelstein Ariel, Michowitz Yoav, Abashidze Anastasia, Miller Hylton, Keren Gad, George Jacob

机构信息

The Department of Cardiology, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, Israel.

出版信息

Atherosclerosis. 2005 Apr;179(2):353-9. doi: 10.1016/j.atherosclerosis.2004.10.020. Epub 2004 Dec 22.

DOI:10.1016/j.atherosclerosis.2004.10.020
PMID:15777553
Abstract

BACKGROUND

The prevalence of coronary ectasia (CE) appears to rise in recent years. However, the pathogenetic mechanisms that underlie this entity are not understood. We hypothesized that dysregulation of circulating matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) contributes to ectasia formation. We also evaluated the association of MMP with inflammatory or the neurohormonal markers.

METHODS

We screened coronary angiographic procedures conducted in our hospital. Thirty-four patients with CEs were identified; 17 with a single ectasia and 17 with generalized ectasias. Two control groups; patients with atherosclerotic coronary disease (n=26) and patients with normal coronary arteries (n=27) were chosen randomly. Serum levels of MMP-2, MMP-3 and TIMP-1 were determined by ELISA. Pro B-type natriuretic peptide (proBNP) and high sensitivity C-reactive protein (hsCRP) serum levels were also measured.

RESULTS

Serum levels of MMP-2, MMP-3, TIMP-1, proBNP and hsCRP did not differ between the three groups of patients. However, subgroup analysis demonstrated that MMP-3 level is significantly lower in patients with generalized CEs compared to those with single vessel ectasia. We also found a statistically significant correlation between proBNP and MMP-2/TIMP-1 (for MMP-2: r(2)=0.3, p=0.003 and for TIMP-1 r(2)=0.42, p<0.000l). By performing subgroup analysis we found that this correlation is only demonstrated in patients with CEs. No correlation was demonstrated between hsCRP and MMPs/TIMP.

CONCLUSIONS

These observations suggest that MMP/TIMP imbalance is present in patients with generalized CE and may contribute to ectasia formation. This imbalance could be mediated by BNP.

摘要

背景

近年来,冠状动脉扩张(CE)的患病率似乎有所上升。然而,导致这一病症的发病机制尚不清楚。我们推测循环基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)的失调促成了扩张的形成。我们还评估了MMP与炎症或神经激素标志物之间的关联。

方法

我们筛查了在我院进行的冠状动脉造影检查。确定了34例CE患者;17例为单发扩张,17例为广泛性扩张。随机选择两个对照组;患有动脉粥样硬化性冠状动脉疾病的患者(n = 26)和冠状动脉正常的患者(n = 27)。通过酶联免疫吸附测定法测定血清MMP - 2、MMP - 3和TIMP - 1水平。还测量了B型利钠肽原(proBNP)和高敏C反应蛋白(hsCRP)血清水平。

结果

三组患者的血清MMP - 2、MMP - 3、TIMP - 1、proBNP和hsCRP水平无差异。然而,亚组分析表明,与单发血管扩张患者相比,广泛性CE患者的MMP - 3水平显著降低。我们还发现proBNP与MMP - 2/TIMP - 1之间存在统计学显著相关性(对于MMP - 2:r(2)=0.3,p = 0.003;对于TIMP - 1,r(2)=0.42,p<0.0001)。通过进行亚组分析,我们发现这种相关性仅在CE患者中表现出来。hsCRP与MMPs/TIMP之间未显示相关性。

结论

这些观察结果表明,广泛性CE患者存在MMP/TIMP失衡,可能促成扩张的形成。这种失衡可能由BNP介导。

相似文献

1
Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia.冠状动脉扩张患者循环中蛋白水解、炎症和神经激素标志物之间的时间关联。
Atherosclerosis. 2005 Apr;179(2):353-9. doi: 10.1016/j.atherosclerosis.2004.10.020. Epub 2004 Dec 22.
2
Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia.冠状动脉扩张中的基质金属蛋白酶与炎症标志物:它们与冠状动脉扩张严重程度的关系。
Coron Artery Dis. 2008 Dec;19(8):559-63. doi: 10.1097/MCA.0b013e3283109079.
3
Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.外周循环 CD14+单核细胞中基质金属蛋白酶 9/金属蛋白酶组织抑制剂 1 比值与冠状动脉疾病进展的关系。
Am J Cardiol. 2010 Feb 15;105(4):429-34. doi: 10.1016/j.amjcard.2009.10.013. Epub 2010 Jan 5.
4
Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.辛伐他汀撤药对高胆固醇血症患者血清基质金属蛋白酶的影响。
Eur J Clin Invest. 2006 Feb;36(2):76-84. doi: 10.1111/j.1365-2362.2006.01598.x.
5
Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者血清中基质金属蛋白酶 1、2、3、7、8、9 和金属蛋白酶组织抑制剂 1、4 的同时上调。
Respirology. 2012 Aug;17(6):1006-12. doi: 10.1111/j.1440-1843.2012.02197.x.
6
The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.基质金属蛋白酶及其组织抑制剂在炎症性肠病中的作用。
Dig Dis. 2012;30(3):289-95. doi: 10.1159/000336995. Epub 2012 Jun 20.
7
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.强直性脊柱炎患者血清基质金属蛋白酶及金属蛋白酶组织抑制剂:MMP-3是疾病活动度可重复的敏感且特异生物标志物。
Rheumatology (Oxford). 2006 Apr;45(4):414-20. doi: 10.1093/rheumatology/kei208. Epub 2005 Nov 15.
8
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.乳腺癌患者接受治疗性手术后,蛋白水解失衡得以逆转。
Int J Cancer. 2004 May 1;109(5):782-5. doi: 10.1002/ijc.20009.
9
Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.严重脓毒症中基质金属蛋白酶及其组织抑制剂的动态变化。
J Crit Care. 2011 Dec;26(6):550-5. doi: 10.1016/j.jcrc.2011.02.011. Epub 2011 May 6.
10
Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.代谢综合征患者循环中基质金属蛋白酶(MMP)-8、MMP-9水平及促炎标志物升高。
Clin Chim Acta. 2009 May;403(1-2):173-7. doi: 10.1016/j.cca.2009.02.013. Epub 2009 Feb 28.

引用本文的文献

1
Coronary Artery Aneurysm or Ectasia as a Form of Coronary Artery Remodeling: Etiology, Pathogenesis, Diagnostics, Complications, and Treatment.冠状动脉瘤或扩张作为冠状动脉重塑的一种形式:病因、发病机制、诊断、并发症及治疗
Biomedicines. 2024 Sep 2;12(9):1984. doi: 10.3390/biomedicines12091984.
2
Anticoagulant and antiplatelet treatment effects on the incidence of major cardiovascular events in patients with coronary artery ectasia: An updated systematic review.抗栓和抗血小板治疗对冠状动脉瘤患者主要心血管事件发生率的影响:一项更新的系统评价。
Indian Heart J. 2024 Jul-Aug;76(4):247-253. doi: 10.1016/j.ihj.2024.07.001. Epub 2024 Jul 14.
3
Insights into lipid metabolism and immune-inflammatory responses in the pathogenesis of coronary artery ectasia.
冠状动脉扩张发病机制中脂质代谢与免疫炎症反应的见解
Front Physiol. 2023 Jan 25;14:1096991. doi: 10.3389/fphys.2023.1096991. eCollection 2023.
4
Systemic Immune Inflammation Index is a Novel Marker in Predicting the Presence and Severity of Isolated Coronary Artery Ectasia.全身免疫炎症指数是预测孤立性冠状动脉瘤扩张存在和严重程度的新标志物。
Arq Bras Cardiol. 2023 Jan 9;120(1):e20220056. doi: 10.36660/abc.20220056. eCollection 2023.
5
Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.冠状动脉扩张中的炎症生物标志物:系统评价与荟萃分析
Diagnostics (Basel). 2022 Apr 19;12(5):1026. doi: 10.3390/diagnostics12051026.
6
Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma.冠状动脉扩张患者的治疗与预后:旧难题的当前证据与新机遇
Front Cardiovasc Med. 2022 Feb 4;8:805727. doi: 10.3389/fcvm.2021.805727. eCollection 2021.
7
Underlying factors relating to acute myocardial infarction for coronary artery ectasia patients.冠状动脉扩张患者急性心肌梗死的相关潜在因素。
Medicine (Baltimore). 2020 Sep 4;99(36):e21983. doi: 10.1097/MD.0000000000021983.
8
Clinical indicators and coronary angiographic features of expansive arterial remodelling in patients with abdominal aortic aneurysms.腹主动脉瘤患者中动脉重构扩张的临床指标和冠状动脉造影特征。
PLoS One. 2019 Jul 16;14(7):e0219730. doi: 10.1371/journal.pone.0219730. eCollection 2019.
9
Predictive value of neutrophil to lymphocyte ratio for the presence of coronary artery ectasia in patients with aortic aneurysms.中性粒细胞与淋巴细胞比值对主动脉瘤患者冠状动脉扩张存在情况的预测价值。
Int J Cardiol Heart Vessel. 2014 Aug 15;4:30-34. doi: 10.1016/j.ijchv.2014.08.002. eCollection 2014 Sep.
10
Cytokine Disturbances in Coronary Artery Ectasia Do Not Support Atherosclerosis Pathogenesis.冠状动脉扩张症中的细胞因子紊乱并不支持动脉粥样硬化发病机制。
Int J Mol Sci. 2018 Jan 16;19(1):260. doi: 10.3390/ijms19010260.